Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Moderate Active Ulcerative Colitis”

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT05061446
What this trial is testing

Etrasimod Dose-Ranging Versus Placebo as Induction Therapy Study in Adult Japanese Subjects With Moderately to Severely Active Ulcerative Colitis

Who this might be right for
Ulcerative Colitis
Pfizer 54
Early research (Phase 1)Not Yet RecruitingNCT07760831
What this trial is testing

A Trial of HRS-7085 Tablets in Patients With Moderate to Severe Active Ulcerative Colitis

Who this might be right for
Moderate to Severe Ulcerative Colitis
Jiangsu HengRui Medicine Co., Ltd. 8
Testing effectiveness (Phase 2)Ended earlyNCT03844932
What this trial is testing

A Study Evaluating the Efficacy and Safety of ST-0529 in Subjects With Moderately to Severely Active Ulcerative Colitis

Who this might be right for
Colitis, Ulcerative
Sublimity Therapeutics Holdco Limited 235
Large-scale testing (Phase 3)Study completedNCT01059344
What this trial is testing

Efficacy and Safety of Asacol™ 4.8 g/Day (800 mg Tablets) for the Treatment of Active Ulcerative Colitis

Who this might be right for
Ulcerative Colitis
Tillotts Pharma AG 281
Large-scale testing (Phase 3)Study completedNCT00336492
What this trial is testing

The Safety and Efficacy of Infliximab(REMICADE ) in Pediatric Patients With Moderately to SeverelyActive Ulcerative Colitis

Who this might be right for
Ulcerative Colitis
Centocor, Inc. 60
Testing effectiveness (Phase 2)Active Not RecruitingNCT05611671
What this trial is testing

Evaluate MORF-057 in Adults With Moderately to Severely Active UC

Who this might be right for
Inflammatory Bowel DiseasesColitis, Ulcerative
Morphic Therapeutic, Inc. (A Wholly Owned Subsidiary of Eli Lilly and Company) 280
Large-scale testing (Phase 3)Looking for participantsNCT05076175
What this trial is testing

A Study Investigating Oral Ozanimod (RPC1063) in Pediatric Participants With Moderate to Severe Active Ulcerative Colitis

Who this might be right for
Colitis, Ulcerative
Bristol-Myers Squibb 120
Large-scale testing (Phase 3)Study completedNCT02165215
What this trial is testing

The Efficacy and Safety of Etrolizumab Treatment in Maintenance of Disease Remission in Ulcerative Colitis (UC) Participants Who Are Naive to Tumor Necrosis Factor (TNF) Inhibitors

Who this might be right for
Colitis, Ulcerative
Hoffmann-La Roche 359
Large-scale testing (Phase 3)Active Not RecruitingNCT05535946
What this trial is testing

ABTECT - Maintenance

Who this might be right for
Ulcerative Colitis
Abivax S.A. 1,116
Large-scale testing (Phase 3)Ended earlyNCT02954159
What this trial is testing

Vedolizumab Monotherapy Vs Combination Therapy With Tacrolimus in UC

Who this might be right for
Ulcerative Colitis
Medical College of Wisconsin 4
Testing effectiveness (Phase 2)Study completedNCT01506362
What this trial is testing

Efficacy, Pharmacodynamics, Safety and Tolerability of Oral BL-7040 in Patients With Moderately Active Ulcerative Colitis

Who this might be right for
Ulcerative Colitis
BioLineRx, Ltd. 22
Large-scale testing (Phase 3)Study completedNCT05784246
What this trial is testing

Mirikizumab (LY3074828) in Pediatric Participants With Moderately to Severely or Active Ulcerative Colitis

Who this might be right for
Ulcerative Colitis
Eli Lilly and Company 63
Large-scale testing (Phase 3)Study completedNCT05507203
What this trial is testing

ABTECT-1 - ABX464 Treatment Evaluation for Ulcerative Colitis Therapy -1

Who this might be right for
Ulcerative Colitis
Abivax S.A. 639
Not applicableActive Not RecruitingNCT05817942
What this trial is testing

Prospective Observational Study of Effectiveness and Safety of Filgotinib in Participants With Ulcerative Colitis (UC)

Who this might be right for
Ulcerative Colitis
Alfasigma S.p.A. 509
Large-scale testing (Phase 3)Looking for participantsNCT06488625
What this trial is testing

Efficacy and Safety of Oral Controlled-Ileocolonic-Release Nicotinamide (CICR-NAM) in Patients With Mild to Moderately Active Ulcerative Colitis

Who this might be right for
Ulcerative Colitis, Unspecified
University Hospital Schleswig-Holstein 459
Testing effectiveness (Phase 2)Study completedNCT02337608
What this trial is testing

Efficacy and Safety of GLPG1205 in Subjects With Active Ulcerative Colitis

Who this might be right for
Ulcerative Colitis
Lakefront Biotherapeutics NV 64
Testing effectiveness (Phase 2)Study completedNCT02493712
What this trial is testing

A Phase 2a, Multicenter, Randomized, Double-blind, Parallel Group, Placebo-controlled Trial of IBD98-M

Who this might be right for
Colitis, Ulcerative
Holy Stone Healthcare Co., Ltd 51
Large-scale testing (Phase 3)Study completedNCT01045018
What this trial is testing

A BE Study Comparing Mesalamine 400 mg to ASACOL® 400 mg in Patients With Mild To Moderately Active Ulcerative Colitis

Who this might be right for
Mild to Moderate Ulcerative Colitis
EMET Pharmaceuticals, LLC
Large-scale testing (Phase 3)Study completedNCT00488631
What this trial is testing

An Efficacy and Safety Study of Golimumab (CNTO 148) in Participants With Moderately to Severely Active Ulcerative Colitis

Who this might be right for
Colitis, Ulcerative
Janssen Research & Development, LLC 1,228
Post-approval studies (Phase 4)Active Not RecruitingNCT06964113
What this trial is testing

Filgotinib 200 mg in Korean Participants With Moderately to Severely Active Ulcerative Colitis Under Routine Clinical Practice

Who this might be right for
Ulcerative Colitis
Eisai Korea Inc. 94
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation